Crossmark

HPDA-based tubule-targeting nanoplatform alleviates oxidative stress and ferroptosis for the reversal of renal interstitial fibrosis

Published Online: 2025-12-13

Authors

Xiao, Zheng

Luo, Peng

Li, Guoli

Tan, Huifang

Zhou, Chen

Zeng, Dong

Chen, Yinyin https://orcid.org/0009-0002-5034-404X
Li, Ying https://orcid.org/0000-0002-5590-0765
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82200775)

National Natural Science Foundation of China (82300825)

National Natural Science Foundation of China (82470759)

National Natural Science Foundation of China (82170707)

Natural Science Foundation of Hunan Province (2022JJ40228)

Natural Science Foundation of Hunan Province (2024JJ6273)
License Information

Text and Data Mining valid from 2025-12-13

Version of Record valid from 2026-01-21
More Information

Article History

Received: 5 September 2025

Accepted: 3 December 2025

First Online: 13 December 2025

Declarations

:

: All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Hunan Provincial People’s Hospital (No. 2024114).

: Not applicable.

: The authors declare no competing interests.

Document is current